{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:22:31Z","timestamp":1793413351465,"version":"4.5.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nbd.2025.106889","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T15:06:26Z","timestamp":1743260786000},"page":"106889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["\u03b1-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease"],"prefix":"10.1016","volume":"209","author":[{"given":"Yakum B.","family":"Mingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"Escobar Galvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael X.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106889_bb0005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalised increase in protein carbonyls in the brain in Parkinson\u2019s but not incidental Lewy body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106889_bb0010","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106889_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"Amino","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106889_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-024-01105-0","article-title":"Targeting mitophagy in neurodegenerative diseases","author":"Antico","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2025.106889_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2025.106889_bb0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2025.106889_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.106889_bb0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0055","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.106889_bb0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106889_bb0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.106889_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2025.106889_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jns.2006.05.011","article-title":"Cognitive decline correlates with neuropathological stage in Parkinson\u2019s disease","volume":"248","author":"Braak","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.106889_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2010.09.005","article-title":"Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson\u2019s disease patients","volume":"41","author":"Burguillos","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","article-title":"Disturbed mitochondrial dynamics and neurodegenerative disorders","volume":"11","author":"Burt\u00e9","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2009.08.005","article-title":"Importing mitochondrial proteins: machineries and mechanisms","volume":"138","author":"Chacinska","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106889_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration","volume":"123","author":"Chandra","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2025.106889_bb0105","first-page":"1","article-title":"Parkinson\u2019s disease neurons exhibit alterations in mitochondrial quality control proteins","volume":"9","author":"Chen","year":"2023","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"10.1016\/j.nbd.2025.106889_bb0110","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106889_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","volume":"18","author":"Concha-Marambio","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2025.106889_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson\u2019s disease linked \u03b1-Synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2025.106889_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61757-x","article-title":"The expression level of alpha-synuclein in different neuronal populations is the primary determinant of its prion-like seeding","volume":"10","author":"Courte","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106889_bib941","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518786715","article-title":"Testing the protein propagation hypothesis of Parkinson disease","volume":"12","author":"Dagher","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"issue":"Suppl","key":"10.1016\/j.nbd.2025.106889_bb0145","first-page":"1","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-020-00139-6","article-title":"Protection from \u03b1-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20","volume":"6","author":"De Miranda","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease","volume":"119","author":"Del Tredici","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-42139-1_2","article-title":"Dopamine metabolism and reactive oxygen species production","volume":"25\u201347","author":"Delcambre","year":"2016","journal-title":"Mitochondr. Mechan. Degenerat. Repair Parkinson\u2019s Diseas."},{"key":"10.1016\/j.nbd.2025.106889_bb0170","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106889_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102216","article-title":"Targeting mitochondrial calcium pathways as a potential treatment against Parkinson\u2019s disease","volume":"89","author":"Dey","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nbd.2025.106889_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0185","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.22172","article-title":"Lesions outside the CNS in Parkinson\u2019s disease","volume":"24","author":"Djaldetti","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","article-title":"Phase and Electron microscopic observations of Lewy bodies and melanin granules in the substantia Nigra and locus Caeruleus in Parkinson\u2019s disease","volume":"24","author":"Duffy","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0195","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molmed.2005.01.001","article-title":"Gene dosage and pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Eriksen","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jmb.2019.06.031","article-title":"Quality control in neurons: Mitophagy and other selective autophagy mechanisms","volume":"432","author":"Evans","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2025.106889_bb0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","article-title":"Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation","volume":"11","author":"Fasano","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.10486","article-title":"Nigral glutathione deficiency is not specific for idiopathic Parkinson\u2019s disease","volume":"18","author":"Fitzmaurice","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit","volume":"71","author":"Flint Beal","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0230","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00688674","article-title":"Ultrastructure of Lewy bodies in the stellate ganglion","volume":"34","author":"Forno","year":"1976","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.410200403","article-title":"Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys","volume":"20","author":"Forno","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0245","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","article-title":"Neural activity controls the synaptic accumulation of alpha-synuclein","volume":"25","author":"Fortin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1154-0","article-title":"Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson\u2019s disease","volume":"9","author":"Franco-Iborra","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0255","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23747","article-title":"Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport","volume":"72","author":"Freundt","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2025.106889_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-associated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.106889_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00672-8","article-title":"A topographical atlas of \u03b1-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs","volume":"10","author":"Geertsma","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.nbd.2025.106889_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.nbd.2025.106889_bb0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0285","first-page":"1242","article-title":"Immunotherapies for Alzheimer\u2019s disease","volume":"382","author":"Golde","year":"2023","journal-title":"Science (1979)"},{"key":"10.1016\/j.nbd.2025.106889_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson\u2019s disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2025.106889_bb0295","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nbd.2025.106889_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-47027-8","article-title":"Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology","volume":"15","author":"Goralski","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106889_bb0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1353-8020(03)00016-6","article-title":"Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study","volume":"9","author":"Gouider-Khouja","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"\u03b1-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Guardia-Laguarta","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0315","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/ijms20030748","article-title":"Parkin interacts with apoptosis-inducing factor and interferes with its translocation to the nucleus in neuronal cells","volume":"20","author":"Guida","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106889_bb0320","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/mds.22481","article-title":"No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism","volume":"24","author":"Halliday","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0325","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"\u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.106889_bb0330","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: a toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106889_bb0335","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0340","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1471-4159.2001.00160.x","article-title":"Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease?","volume":"76","author":"Hartmann","year":"2001","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.nbd.2025.106889_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8","article-title":"An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene","volume":"15","author":"Hayashi","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0345","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","article-title":"Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis","volume":"22","author":"Henderson","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105687","article-title":"The roles of connectivity and neuronal phenotype in determining the pattern of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"168","author":"Henderson","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106889_bb0360","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0365","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroscience.2018.03.026","article-title":"Phosphorylated \u03b1-Synuclein accumulations and Lewy body-like pathology distributed in Parkinson\u2019s disease-related brain areas of aged Rhesus monkeys treated with MPTP","volume":"379","author":"Huang","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106889_bb0370","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0375","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/brain\/awac313","article-title":"DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy","volume":"145","author":"Imberechts","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106889_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2025.106889_bb0385","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JPD-223161","article-title":"Cardiac alpha-Synuclein is present in alpha-Synucleinopathies","volume":"12","author":"Javanshiri","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0395","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of \u03b1-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0400","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1212\/WNL.0b013e3182703f76","article-title":"Bid signal pathway components are identified in the temporal cortex with Parkinson disease","volume":"79","author":"Jiang","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.201008084","article-title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL","volume":"191","author":"Jin","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2025.106889_bb0410","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.106889_bb0415","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by \u03b1-synuclein is rescued by PINK1, Parkin and DJ-1","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2025.106889_bb0420","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainres.2014.05.007","article-title":"Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"1571","author":"Kawamoto","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.106889_bb0425","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106889_bb0430","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/mds.27383","article-title":"Disease modification for Parkinson\u2019s disease: axonal regeneration and trophic factors","volume":"33","author":"Kordower","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0435","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0440","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-022-01403-x","article-title":"Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies","volume":"10","author":"Koss","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106889_bb0445","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2015.08.079","article-title":"PKA phosphorylation of NCLX reverses mitochondrial calcium overload and depolarization, promoting survival of PINK1-deficient dopaminergic neurons","volume":"13","author":"Kostic","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106889_bb0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2025.106889_bb0455","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00738-7","article-title":"A skin-specific \u03b1-Synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease","volume":"10","author":"Kuang","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0460","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in early Parkinson\u2019s disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.nbd.2025.106889_bib943","first-page":"50","article-title":"International multicenter analysis of brain structure across clinical stages of Parkinson\u2019s disease","volume":"10","author":"Laansma","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104021","article-title":"Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: a randomised, double-blind, placebo-controlled phase 1a trial","volume":"80","author":"Levin","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nbd.2025.106889_bb0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","article-title":"Energy matters: presynaptic metabolism and the maintenance of synaptic transmission","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0470","series-title":"Paralysis agitans. I. Pathologische Anatomie. Lewandowsky\u2019s Handbuch der Neurologie, 3. Band: Spez. Neurologie II","first-page":"920","author":"Lewy","year":"1912"},{"key":"10.1016\/j.nbd.2025.106889_bb0480","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0485","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106889_bb0490","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2017.08.044","article-title":"Mitochondrial calcium imbalance in Parkinson\u2019s disease","volume":"663","author":"Ludtmann","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2025.106889_bb0495","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1523\/JNEUROSCI.1659-16.2016","article-title":"Monomeric alpha-Synuclein exerts a physiological role on brain ATP synthase","volume":"36","author":"Ludtmann","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-Synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106889_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1469-5","article-title":"LRRK2 deficiency induced mitochondrial Ca2+ efflux inhibition can be rescued by Na+\/Ca2+\/Li+ exchanger upregulation","volume":"10","author":"Ludtmann","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0510","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0515","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106889_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0525","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0530","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0535","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0540","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2025.106889_bb0545","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of Lixisenatide in early Parkinson\u2019s disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0550","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","article-title":"Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles","volume":"99","author":"Middleton","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.nbd.2025.106889_bb0555","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2025.106889_bb0560","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s007020050028","article-title":"Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain","volume":"107","author":"Mogi","year":"2000","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2025.106889_bb0565","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/mds.10264","article-title":"Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein","volume":"17","author":"Morales","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0570","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.51.3.890","article-title":"Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q","volume":"51","author":"Mori","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0575","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1440-1789.2003.00476.x","article-title":"Genotype-phenotype correlation: familial Parkinson disease","volume":"23","author":"Mori","year":"2003","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2025.106889_bb0580","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0585","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-Synuclein reduces neurotransmitter release by inhibiting synaptic vesicle Reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0590","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","article-title":"Mitochondria-associated programmed cell death as a therapeutic target for age-related disease","volume":"55","author":"Nguyen","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0595","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.07.023","article-title":"Neuropathological findings in PINK1-associated Parkinson\u2019s disease","volume":"78","author":"Nyb\u00f8","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0600","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03270-6","article-title":"Sustained effect of prasinezumab on Parkinson\u2019s disease motor progression in the open-label extension of the PASADENA trial","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2025.106889_bb0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106889_bib942","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroimage.2019.03.001","article-title":"Predictive model of spread of Parkinson\u2019s pathology using network diffusion","volume":"192","author":"Pandya","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2025.106889_bb0615","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson\u2019s disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.106889_bb0620","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","article-title":"Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function","volume":"111","author":"Parra-Rivas","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0625","series-title":"Loss of \u03b1-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons","first-page":"eNeuro","volume":"4","author":"Pathak","year":"2017"},{"key":"10.1016\/j.nbd.2025.106889_bb0630","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/mds.29450","article-title":"A Double-blind, randomized, placebo-controlled trial of Ursodeoxycholic acid (UDCA) in Parkinson\u2019s disease","volume":"38","author":"Payne","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0635","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/ars.2011.4074","article-title":"Mitochondria and programmed cell death in Parkinson\u2019s disease: apoptosis and beyond","volume":"16","author":"Perier","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.106889_bb0640","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0645","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106889_bb0650","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.20587","article-title":"Lewy body Parkinson\u2019s disease in a large pedigree with 77 Parkin mutation carriers","volume":"58","author":"Pramstaller","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0655","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.neuron.2023.02.033","article-title":"Neuronal identity defines \u03b1-synuclein and tau toxicity","volume":"111","author":"Praschberger","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0660","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","article-title":"Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson\u2019s disease","volume":"87","author":"Qualman","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nbd.2025.106889_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00444-w","article-title":"Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity","volume":"9","author":"Ramalingam","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0670","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1523\/JNEUROSCI.1157-19.2019","article-title":"Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease","volume":"39","author":"Rangaraju","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0675","first-page":"142","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"22","author":"Riederer","year":"2021","journal-title":"J. Neurol. Neurochir. Psychiatr."},{"key":"10.1016\/j.nbd.2025.106889_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105685","article-title":"Rotenone induces regionally distinct \u03b1-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl\/6 mice","volume":"167","author":"Rocha","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106675","article-title":"Alpha-synuclein modulates the repair of genomic DNA double-strand breaks in a DNA-PKcs-regulated manner","volume":"201","author":"Rose","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114668","article-title":"The role of \u03b1-synuclein in exocytosis","volume":"373","author":"Runwal","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0695","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106889_bb0700","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.WNL.0000134657.25904.0B","article-title":"Parkin-positive autosomal recessive juvenile parkinsonism with alpha-synuclein-positive inclusions","volume":"63","author":"Sasaki","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0705","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106889_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47227-z","article-title":"Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders","volume":"9","author":"Schaser","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106889_bb0715","doi-asserted-by":"crossref","first-page":"18076","DOI":"10.1074\/jbc.RA120.015319","article-title":"\u03b1-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate","volume":"295","author":"Schechter","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.106889_bb0720","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1460-9568.2008.06055.x","article-title":"Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein","volume":"27","author":"Senior","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0725","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0730","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00615-9","article-title":"Towards improved screening of toxins for Parkinson\u2019s risk","volume":"9","author":"Shan","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106889_bb0735","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","article-title":"\u03b1-Synuclein in synaptic function and dysfunction","volume":"46","author":"Sharma","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0740","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(85)81028-0","article-title":"Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+","volume":"189","author":"Shen","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2025.106889_bb0745","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molbrainres.2005.01.012","article-title":"Absence of inclusion body formation in the MPTP mouse model of Parkinson\u2019s disease","volume":"134","author":"Shimoji","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2025.106889_bb0750","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0755","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2025.106889_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040296","article-title":"Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease","volume":"13","author":"Skou","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.106889_bb0765","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106889_bb0770","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/mds.29170","article-title":"Phase 1\/1b studies of UCB0599, an Oral inhibitor of \u03b1-Synuclein Misfolding, including a randomized study in Parkinson\u2019s disease","volume":"37","author":"Smit","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0775","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106889_bb0780","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.24346","article-title":"Defining neurodegeneration on Guam by targeted genomic sequencing","volume":"77","author":"Steele","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0785","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1093\/hmg\/ddt301","article-title":"Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation","volume":"22","author":"Su","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106889_bb0790","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011353","article-title":"Calcium control of neurotransmitter release","volume":"4","author":"S\u00fcdhof","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2025.106889_bb0795","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/pri.23582","article-title":"The pathology roadmap in Parkinson disease","volume":"7","author":"Surmeier","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.nbd.2025.106889_bb0800","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1034072","article-title":"miRNA and antisense oligonucleotide-based \u03b1-synuclein targeting as disease-modifying therapeutics in Parkinson\u2019s disease","volume":"13","author":"Suvarna","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106889_bb0810","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cne.23901","article-title":"Brain region-dependent differential expression of alpha-synuclein","volume":"524","author":"Taguchi","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2025.106889_bb0815","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12565-018-0464-8","article-title":"Expression of \u03b1-synuclein is regulated in a neuronal cell type-dependent manner","volume":"94","author":"Taguchi","year":"2019","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.nbd.2025.106889_bb0820","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1212\/WNL.0000000000002744","article-title":"Absence of Lewy pathology associated with PINK1 homozygous mutation","volume":"86","author":"Takanashi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0825","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.nbd.2025.106889_bb0830","first-page":"119","article-title":"Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons","volume":"150","author":"Tompkins","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0835","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2003.10.072","article-title":"The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain","volume":"1004","author":"Totterdell","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.106889_bb0840","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106889_bb0845","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.56.4.555","article-title":"Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations","volume":"56","author":"Van De Warrenburg","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0850","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","article-title":"Synucleins regulate the kinetics of synaptic vesicle endocytosis","volume":"34","author":"Vargas","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0855","article-title":"Network analysis of \u03b1-synuclein pathology progression reveals p21-activated kinases as regulators of vulnerability","author":"Vatsa","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2025.106889_bb0860","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047993","article-title":"Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson\u2019s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: the \u201cExenatide-PD3\u201d study","volume":"11","author":"Vijiaratnam","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.nbd.2025.106889_bb0865","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106889_bb0870","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","article-title":"Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease","volume":"21","author":"Viswanath","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106889_bb0875","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106889_bb0880","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106889_bb0885","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","article-title":"Parkinson\u2019s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction","volume":"121","author":"Wang","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106889_bb0890","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","article-title":"Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration","volume":"7","author":"Wang","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106889_bb0895","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","article-title":"Monomeric synucleins generate membrane curvature","volume":"288","author":"Westphal","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"219","key":"10.1016\/j.nbd.2025.106889_bb0900","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"1979","author":"William Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106889_bb0905","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106889_bb0910","first-page":"S3","article-title":"Levodopa therapy for Parkinson disease: a look backward and forward","volume":"86","author":"Witt","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106889_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076338","article-title":"Genetic evidence for Endolysosomal dysfunction in Parkinson\u2019s disease: a critical overview","volume":"24","author":"Yahya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106889_bb0920","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1353-8020(98)00015-7","article-title":"Clinical, pathologic and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation","volume":"4","author":"Yamamura","year":"1998","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106889_bb0925","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106889_bb0930","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8701","article-title":"Ca2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons","volume":"8","author":"Zampese","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.nbd.2025.106889_bb0935","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12607","article-title":"Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson\u2019s disease in mouse models","volume":"25","author":"Zhang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.nbd.2025.106889_bb0940","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:55:35Z","timestamp":1745218535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":190,"alternative-id":["S0969996125001056"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106889","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106889"}}